Note: Ingredients listed on restricted chemical lists
EC/CAS
872-50-4
Name of the chemical
N-Methyl-2-Pyrrolidone; 1-methyl-2-pyrrolidone (NMP)
Concentration
3-7 1-5
EC/CAS
64742-95-6
Name of the chemical
Solvent naphtha (petroleum), light arom
Concentration
1-5
EC/CAS
111-76-2
Name of the chemical
Ethylene glycol monobutyl ether (EGBE)
Concentration
0.5-1.5
General Information
Version
9
Revision date
2026-01-01
Product name
NEUTRAL BASE WR URETHANE
1.2.1 Relevant identified uses
Industrial applications
Manufacturer Name
PPG Industries, Inc
Emergency telephone
1-888-774-2001
Icons in SDS
Company Information
company name
PPG Industries, Inc
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H227, H315, H317, H319, H360, H373
Hazard statements
Code
Statements
H227
Combustible liquid
Section 2
SECTION 2: Hazards identification
Classification of the substance or mixture
Product definition
Mixture Classification according to UK CLP/GHS Not classified
Signal word
No signal word.
Hazard statements
No known significant effects or critical hazards.
Prevention
Not applicable.
Response
Not applicable.
Storage
Not applicable.
Disposal
Dispose of contents and container in accordance with all local, regional, national and international regulations. P501
Supplemental label elements
Not applicable. elements
Annex XVII - Restrictions on the manufacture, placing on the market and use of certain dangerous substances, mixtures and articles
Not applicable.
Special packaging requirements
Containers to be fitted Not applicable. with child-resistant fastenings
Tactile warning of danger
Not applicable.
2.3 Other hazards
Product meets the criteria This mixture does not contain any substances that are assessed to be a PBT or a for PBT or vPvB according vPvB. to Regulation (EC) No.
Other hazards which do not result in classification
None known.
2.1 Classification of the substance or mixture
Product definition : Mixture Classification according to UK CLP/GHS Not classified. The product is not classified as hazardous according to UK CLP Regulation SI 2019/720 as amended. See Section 11 for more detailed information on health effects and symptoms.
